Fragment-based development of HCV protease inhibitors for the treatment of hepatitis C

Curr Comput Aided Drug Des. 2012 Mar;8(1):55-61. doi: 10.2174/157340912799218516.

Abstract

A novel computational technology based on fragmentation of the chemical compounds has been used for the fast and efficient prediction of activities of prospective protease inhibitors of the hepatitis C virus. This study spans over a discovery cycle from the theoretical prediction of new HCV NS3 protease inhibitors to the first cytotoxicity experimental tests of the best candidates. The measured cytotoxicity of the compounds indicated that at least two candidates would be suitable further development of drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Computer Simulation
  • Hepacivirus / drug effects
  • Hepacivirus / enzymology*
  • Hepatitis C / drug therapy
  • Hepatitis C / enzymology
  • Humans
  • Linear Models
  • Models, Biological
  • Peptide Hydrolases / metabolism*
  • Protease Inhibitors / chemistry*
  • Protease Inhibitors / pharmacology*
  • Quantitative Structure-Activity Relationship*

Substances

  • Antiviral Agents
  • Protease Inhibitors
  • Peptide Hydrolases